HIV vaccines 1983-2003
- PMID: 12835708
- DOI: 10.1038/nm0703-874
HIV vaccines 1983-2003
Abstract
Twenty years after the discovery of HIV, there is still no vaccine. This year, an envelope vaccine aimed at stimulating neutralizing antibodies was unable to protect against infection in phase 3 trials. But more than 20 HIV vaccines designed to stimulate T-cell responses are being developed. Will any of them work?
Similar articles
-
Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers.Vaccine. 2007 Jan 5;25(3):510-8. doi: 10.1016/j.vaccine.2006.07.050. Epub 2006 Aug 10. Vaccine. 2007. PMID: 17049679 Clinical Trial.
-
The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?Nat Rev Immunol. 2002 Apr;2(4):283-91. doi: 10.1038/nri779. Nat Rev Immunol. 2002. PMID: 12001999 Review.
-
New hope for an AIDS vaccine.Nat Rev Immunol. 2002 Apr;2(4):239-50. doi: 10.1038/nri776. Nat Rev Immunol. 2002. PMID: 12001995 Review.
-
HIV/AIDS vaccines: 2007.Clin Pharmacol Ther. 2007 Dec;82(6):686-93. doi: 10.1038/sj.clpt.6100408. Epub 2007 Oct 31. Clin Pharmacol Ther. 2007. PMID: 17971817 Review.
-
Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.J Virol. 2005 Aug;79(15):9872-84. doi: 10.1128/JVI.79.15.9872-9884.2005. J Virol. 2005. PMID: 16014948 Free PMC article.
Cited by
-
CpG ODNs treatments of HIV-1 infected patients may cause the decline of transmission in high risk populations - a review, hypothesis and implications.Virus Genes. 2005 Mar;30(2):251-66. doi: 10.1007/s11262-004-5632-2. Virus Genes. 2005. PMID: 15744581 Review.
-
A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs.Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13584-9. doi: 10.1073/pnas.0405297101. Epub 2004 Sep 3. Proc Natl Acad Sci U S A. 2004. PMID: 15347807 Free PMC article.
-
Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine.J Exp Med. 2006 Mar 20;203(3):607-17. doi: 10.1084/jem.20052005. Epub 2006 Feb 27. J Exp Med. 2006. PMID: 16505141 Free PMC article.
-
Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine.J Virol. 2007 May;81(10):5202-11. doi: 10.1128/JVI.02881-06. Epub 2007 Mar 7. J Virol. 2007. PMID: 17344296 Free PMC article.
-
Nine crystal structures determine the substrate envelope of the MDR HIV-1 protease.Protein J. 2011 Mar;30(3):173-83. doi: 10.1007/s10930-011-9316-2. Protein J. 2011. PMID: 21394574
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources